Ajanta Pharma Promoter Sells 2.76% Stake Worth Rs 1,024 Crore to Mutual Funds
Ravi Agrawal Trust, a promoter entity of Ajanta Pharma, sold a 2.76% stake worth approximately Rs 1,024 crore through a block deal at Rs 2,968 per share. Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquired the shares. Following the sale, the promoter's holding decreased from 13% to 10.24%, and the combined promoter group stake fell to 63.49%. Ajanta Pharma has shown strong earnings growth and robust performance in its pharmaceutical segments.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is positive (68/100). Lens Score 40/100 — moderate-to-low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- news18— balanced framing, neutral sentiment
- economictimes— balanced framing, positive sentiment
AI Analysis
The articles primarily present financial and corporate information without political framing. Coverage focuses on market transactions and company performance, reflecting business and investment perspectives. There is no evident political viewpoint or partisan framing, as the sources report factual data on share sales and company earnings.
The tone across the articles is neutral to positive, emphasizing the significant share sale alongside Ajanta Pharma's strong financial results and market position. The coverage highlights investor interest and company growth without negative or sensational language, maintaining an informative and balanced sentiment.
How 2 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.